Top Markets
Coin of the day
Kailera Therapeutics, Inc. Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc.

KLRA
Rangering i aksjer #5856
Kailera Therapeutics is a biopharmaceutical company currently advancing through... Kailera Therapeutics is a biopharmaceutical company currently advancing through its clinical development stage, dedicated to cultivating a varied portfolio of cutting-edge treatments. These therapeutics are specifically engineered to tackle obesity and its associated metabolic disorders. The company distinguishes itself through its focus on innovative methodologies, offering both injectable and orally administered formulations for sustainable weight management. Its most advanced candidate is a groundbreaking dual-action gut hormone receptor agonist, which has reported encouraging outcomes in its initial clinical investigations.
Aksjekurs
$18.40
Markedsverdi
$2.38B
Endring (1 dag)
-0.22%
Endring (1 år)
-
Land
US
Handel Kailera Therapeutics, Inc. (KLRA)

Kategori

Historikk for aksjesplitt for Kailera Therapeutics, Inc. (KLRA)
Aksjen Kailera Therapeutics, Inc. (symbol: KLRA) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 27, 2026.
Én KLRA-aksje kjøpt før Aug 27, 2026 tilsvarer i dag 0 KLRA-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH